Company intelligence / Profile preview

Acticomp

Saint-Petersburg, Saint-Petersburg, Russiaacticomp.ru ↗

Ownership: Private
Employees: ~67
Development stage: Commercial

Overview

Acticomp is one of Russia’s largest manufacturers and developers of active pharmaceutical substances. The company operates two GMP-compliant production sites in St. Petersburg with a capacity up to 250 tons per year. Its portfolio includes over 60 commercialized APIs and more than 100 additional substances in development. Many products are included in the Russian State List of Vital Medicines.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Cooperates with large Russian and foreign drug manufacturers

Beyond the preview

Go deeper on Acticomp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acticomp.

Explore the full profile